Video about the center
Currently, PHARMBIOTEST is the only research company in Ukraine with a closed cycle of processes, when all stages of the research (clinical, bioanalytical and statistical) are carried out in one place, by one legal entity responsible for maintaining the highest quality of each procedure.
The company has a complex of buildings with the total area of 4500 square meters, with a 36-bed inpatient unit, used to provide therapeutic and prophylactic care to patients and to diagnose a wide range of diseases. The company employs a team of medical specialists: therapist, cardiologist, obstetrician-gynecologist, traumatologist, endocrinologist, neuropathologist, ultrasound diagnostics doctors. PHARMBIOTEST’s Clinical Diagnostic Laboratory, is equipped with the state of the art automatic analyzers for carrying out a full range of clinical laboratory studies including hematological, biochemical studies, enzyme immunoassay and DNA diagnostics.
If you have any questions regarding the planning and conduct of a clinical study, contact our team at contact@pharmbiotest.com.ua ,
call +38 (050) 367 62 33 or fill out the feedback form.
What do you get by ordering a study from us
Full package of services
Our center provides bioequivalence research services, including clinical, bioanalytical and statistical stages, and we also make documents: from the development of a protocol to the preparation of a report.
Quality
Each study is conducted in accordance with Good Clinical Practice (GCP) and Good Laboratory Practice (GLP). The Quality assurance unit (QAU) proceeds according to internal regulations and monitors the compliance of each step of study.
You save money
All stages of the study are carried out by one company, which significantly reduces logistics costs.
Our destinations
News
October 9 - 12, 2018 | Ukraine
The Quality Director of MTZ Clinical Research conducts workshops on the principles of good clinical practice (GCP) accredited by Transcelerate at a partner Research Center in Ukraine.
October 2018
In October 2018, our company passed the audit to confirm compliance of clinical research practice with the appropriate ICH GCP E6 (R2) requirements and Ethical Principles.
